273 related articles for article (PubMed ID: 26850997)
1. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
Craciun I; Fenner AM; Kerns RJ
Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
[TBL] [Abstract][Full Text] [Related]
2. Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.
Guyot N; Wartelle J; Malleret L; Todorov AA; Devouassoux G; Pacheco Y; Jenne DE; Belaaouaj A
Am J Pathol; 2014 Aug; 184(8):2197-210. PubMed ID: 24929239
[TBL] [Abstract][Full Text] [Related]
3. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3.
Hwang TL; Wang WH; Wang TY; Yu HP; Hsieh PW
Bioorg Med Chem; 2015 Mar; 23(5):1123-34. PubMed ID: 25650311
[TBL] [Abstract][Full Text] [Related]
5. Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates.
Korkmaz B; Attucci S; Epinette C; Pitois E; Jourdan ML; Juliano L; Gauthier F
Methods Mol Biol; 2012; 844():125-38. PubMed ID: 22262439
[TBL] [Abstract][Full Text] [Related]
6. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil serine proteases exert proteolytic activity on endothelial cells.
Jerke U; Hernandez DP; Beaudette P; Korkmaz B; Dittmar G; Kettritz R
Kidney Int; 2015 Oct; 88(4):764-75. PubMed ID: 26061547
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D; Zhang J; Korkmaz B; Chalmers JD; Basso J; Lasala D; Fernandez C; Teper A; Mange KC; Perkins WR; Sullivan EJ
Respir Res; 2023 May; 24(1):133. PubMed ID: 37198686
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor.
van den Berg CW; Tambourgi DV; Clark HW; Hoong SJ; Spiller OB; McGreal EP
J Immunol; 2014 Feb; 192(4):1787-95. PubMed ID: 24446515
[TBL] [Abstract][Full Text] [Related]
11. Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice.
Dai R; Cowan C; Heid B; Khan D; Liang Z; Pham CT; Ahmed SA
PLoS One; 2017; 12(2):e0172105. PubMed ID: 28192517
[TBL] [Abstract][Full Text] [Related]
12. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
13. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
[TBL] [Abstract][Full Text] [Related]
15. An optimized method of extracting and quantifying active Neutrophil serine proteases from human whole blood cells.
Basso J; Zhang J; Lasala D; Rose SJ; Chen KJ; Cipolla D
PLoS One; 2022; 17(8):e0272575. PubMed ID: 36044421
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium.
Hiemstra PS; van Wetering S; Stolk J
Eur Respir J; 1998 Nov; 12(5):1200-8. PubMed ID: 9864022
[TBL] [Abstract][Full Text] [Related]
17. N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases.
Santana AB; Lucas SD; Gonçalves LM; Correia HF; Cardote TA; Guedes RC; Iley J; Moreira R
Bioorg Med Chem Lett; 2012 Jun; 22(12):3993-7. PubMed ID: 22595175
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.
Korkmaz B; Horwitz MS; Jenne DE; Gauthier F
Pharmacol Rev; 2010 Dec; 62(4):726-59. PubMed ID: 21079042
[TBL] [Abstract][Full Text] [Related]
19. Local structural plasticity of the
Herdendorf TJ; Stapels DAC; Rooijakkers SHM; Geisbrecht BV
J Biol Chem; 2020 May; 295(22):7753-7762. PubMed ID: 32303641
[TBL] [Abstract][Full Text] [Related]
20. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
